190 related articles for article (PubMed ID: 3906417)
21. Pathogenesis of glucose intolerance in uremia.
DeFronzo RA
Metabolism; 1978 Dec; 27(12 Suppl 2):1866-80. PubMed ID: 723638
[TBL] [Abstract][Full Text] [Related]
22. Red blood cell calcium homeostasis in patients with end-stage renal disease.
Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
[TBL] [Abstract][Full Text] [Related]
23. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
[TBL] [Abstract][Full Text] [Related]
24. Diffusion kinetics of urea, creatinine and uric acid in blood during hemodialysis. Clinical implications.
Descombes E; Perriard F; Fellay G
Clin Nephrol; 1993 Nov; 40(5):286-95. PubMed ID: 8281718
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
26. The effect of hemodialysis on endogenous middle molecules in uremic patients.
Asaba H; Fürst P; Oulés R; Yahiel V; Zimmerman L; Bergström J
Clin Nephrol; 1979 May; 11(5):257-66. PubMed ID: 455822
[TBL] [Abstract][Full Text] [Related]
27. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
[TBL] [Abstract][Full Text] [Related]
28. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
[TBL] [Abstract][Full Text] [Related]
29. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
[TBL] [Abstract][Full Text] [Related]
30. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
Shahbazian H; Zand Moghadam A; Ehsanpour A; Khazaali M
Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664
[TBL] [Abstract][Full Text] [Related]
31. The effect of dialysis on true plasma glucose tolerance in uremia.
Weisinger JR; Reaven GM; Coplon NS; Swenson RS
Trans Am Soc Artif Intern Organs; 1973; 19():277-81. PubMed ID: 4722743
[No Abstract] [Full Text] [Related]
32. [Effect of dialytic treatment and the relation between erythrocyte urea and plasma urea].
Gaiter AM; Paternoster G; Bonfant G; Caneparo G; Alloatti S
Minerva Urol Nefrol; 1991; 43(3):185-90. PubMed ID: 1817343
[TBL] [Abstract][Full Text] [Related]
33. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
Shasha SM; Nusem D; Kanter Y; Weiner F
Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
[TBL] [Abstract][Full Text] [Related]
34. Continuous arteriovenous hemodialysis and hemofiltration in acute renal failure: comparison of uremic control.
Alarabi AA; Wikström B; Danielson BG
Contrib Nephrol; 1991; 93():61-4. PubMed ID: 1802603
[No Abstract] [Full Text] [Related]
35. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
[TBL] [Abstract][Full Text] [Related]
36. Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis.
Kario K; Matsuo T; Yamada T; Matsuo M
Thromb Haemost; 1994 Mar; 71(3):275-9. PubMed ID: 8029788
[TBL] [Abstract][Full Text] [Related]
37. [The significance of transcellular transport kinetics of urea and creatinine for haemodialysis (author's transl)].
Zimmermann E; Pölz E
Wien Klin Wochenschr; 1981 Sep; 93(16):519-21. PubMed ID: 7303697
[TBL] [Abstract][Full Text] [Related]
38. Dialyzable factors from uremic serum increase 125I-fibrinogen binding by normal blood platelets.
Komarnicki M; Krupa D; Kaźmierczak M; Drobnik D; Zozulińska M
Nephron; 1990; 55(4):372-4. PubMed ID: 2202919
[TBL] [Abstract][Full Text] [Related]
39. Valproate plasma protein binding in the uremic condition.
Brewster D; Muir NC
Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
[TBL] [Abstract][Full Text] [Related]
40. Understanding the uremic syndrome through hemodialysis.
Funck-Brentano JL
Biomater Med Devices Artif Organs; 1974; 2(4):321-43. PubMed ID: 4462862
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
